Vaishali Pharma Limited Share Price & Company Info
- Market cap
- ₹86.67 Cras reported by NSE
- 52-week high
- ₹10.4831-OCT-2025
- 52-week low
- ₹4.7530-MAR-2026
- P/E (NSE)
- 19.56
- Face value
- ₹2.00
- Shares issued
- 13,49,99,995
- Volume
- 17,842₹0.01 Cr traded
- Delivery
- 75.40%of traded quantity
- Price band
- 20%₹5.46 – ₹8.18 on 2026-11-02
- Annual volatility
- 57.51%NSE, from daily returns
- Series
- EQrolling settlement
- ISIN
- INE972X01022
- Listed on NSE
- 15-Jan-2020
About Vaishali Pharma Limited
Vaishali Pharma Limited is listed on the National Stock Exchange of India under the symbol VAISHALI in the EQ series. NSE classifies it under the basic industry Pharmaceuticals, part of the Healthcare sector. Its shares were listed on NSE on 15-Jan-2020. Each share has a face value of ₹2.00.
In the end-of-day data for 16 November 2026 the stock closed at ₹7.02, down 0.71% on the day. NSE puts the company's market capitalisation at about ₹86.67 crore, which puts it among the smallest listed companies in India. Over the past 52 weeks it has traded between ₹4.75 and ₹10.48, so the last price is 47.8% above the low and 33.0% below the high.
17,842 shares changed hands that day, and 75.40% of them were taken as delivery rather than squared off intraday. A high delivery share means most of the day's buyers chose to hold the shares; a low one usually means the volume was mostly short-term trading.
EQ is the normal equity series: shares settle on the usual T+1 cycle and intraday trading is allowed.
NSE puts the stock's annualised volatility at 57.51%. That is well above the level of large, established companies, so double-digit swings within a month are common.
Because the share trades below ₹10, it also appears in our list of penny stocks under ₹10, which explains the extra risks that come with low-priced shares.
Vaishali Pharma Limited quarterly results
In the quarter ended June 2026 (un-audited), Vaishali Pharma Limited reported total income of ₹23.47 crore and a net profit of ₹1.49 crore, or ₹0.11 per share. That is a net margin of 6.3% on income.
A year earlier, in the June 2025 quarter, income was ₹24.59 crore with a net profit of ₹1.28 crore. Income has fallen 4.6% year on year. Net profit has risen 16.4%.
Vaishali Pharma Limited was profitable in 5 of the 5 quarters shown below, every one of them. Figures are as filed with NSE, in ₹ crore.
| Quarter ended | Total income | Profit before tax | Net profit | EPS | Status |
|---|---|---|---|---|---|
| June 2026 | 23.47 | 1.73 | 1.49 | 0.11 | Un-Audited |
| March 2026 | 28.19 | 0.18 | 0.27 | 0.02 | Audited |
| December 2025 | 25.54 | 1.82 | 1.30 | 0.10 | Un-Audited |
| September 2025 | 34.29 | 1.66 | 1.18 | -0.49 | Un-Audited |
| June 2025 | 24.59 | 1.74 | 1.28 | 0.10 | Un-Audited |
Vaishali Pharma Limited shareholding pattern
At the end of September 2026, promoters and the promoter group held 31.61% of Vaishali Pharma Limited, with the public holding 68.39%. That is up 5.29 percentage points from 26.32% in June 2025.
| Quarter ended | Promoter & Promoter Group (%) | Public (%) |
|---|---|---|
| September 2026 | 31.61 | 68.39 |
| July 2026 | 30.54 | 69.46 |
| June 2026 | 31.61 | 68.39 |
| March 2026 | 31.61 | 68.39 |
| December 2025 | 31.61 | 68.39 |
| December 2025 | 31.61 | 68.39 |
| September 2025 | 26.32 | 73.68 |
| June 2025 | 26.32 | 73.68 |
Vaishali Pharma Limited share price performance
Over the past year the Vaishali Pharma Limited share price has lost 35.55%, against a fall of 10.92% for the NIFTY 50, so it has underperformed that index by 24.63 percentage points.
Across the 7 periods in the table, the stock beat the NIFTY 50 in 1. Past returns describe what happened; they do not predict what comes next.
| Period | VAISHALI | NIFTY 50 |
|---|---|---|
| 1 month | -22.28% | +1.91% |
| 3 months | -11.70% | -5.20% |
| 6 months | -14.72% | -3.94% |
| 1 year | -35.55% | -10.92% |
| 2 years | -64.08% | -5.29% |
| 3 years | -52.10% | +20.44% |
| 5 years | +88.66% | +30.45% |
Vaishali Pharma Limited vs industry peers
NSE compares Vaishali Pharma Limited with 6 other listed companies in Pharmaceuticals. By market capitalisation it ranks 4 of 7.
Its P/E of 19.56 compares with a median of 32.68 for the other companies in the group: the market is paying considerably less for each rupee of its recent earnings.
| Company | Market cap | Price (₹) | P/E | Promoter % | Qtr income | Qtr net profit |
|---|---|---|---|---|---|---|
| MAKERSL | 115 | 195.50 | — | 0.00 | — | — |
| BALAXI | 108 | 19.59 | 43.61 | 65.99 | 16.50 | -1.25 |
| ALPA | 107 | 50.80 | 24.21 | 57.19 | 29.76 | 1.04 |
| VAISHALI | 87.61 | 6.49 | 19.56 | 31.61 | 23.47 | 1.49 |
| VILINBIO | 79.38 | 52.05 | 41.15 | 56.65 | — | — |
| VINEETLAB | 72.96 | 37.99 | 18.28 | 5.98 | 10.50 | 1.51 |
| ONYX | 65.28 | 36.00 | — | 0.00 | — | — |
Vaishali Pharma Limited announcements, board meetings and corporate actions
Latest announcements
The most recent filings Vaishali Pharma Limited has made with NSE, newest first:
- 17-Oct-2026 · General Updates: Vaishali Pharma Limited has informed the Exchange about General Updates (PDF)
- 15-Oct-2026 · Certificate under SEBI (Depositories and Participants) Regulations, 2018: Vaishali Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 (PDF)
- 29-Sep-2026 · Trading Window: Vaishali Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (PDF)
- 24-Sep-2026 · Shareholders meeting: Vaishali Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2026. Further, the company has informed the Exchange regarding voting results. (PDF)
- 24-Sep-2026 · Shareholders meeting: Vaishali Pharma Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 24, 2026 (PDF)
- 04-Sep-2026 · General Updates: Vaishali Pharma Limited has informed the Exchange about General Updates (PDF)
- 03-Sep-2026 · Copy of Newspaper Publication: Vaishali Pharma Limited has informed the Exchange about Copy of Newspaper Publication (PDF)
- 01-Sep-2026 · General Updates: Book Closure for the 19th AGM (PDF)
Board meetings
- 14-Aug-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters
- 08-Jul-2026 · Fund Raising: To consider Fund Raising
- 02-Jul-2026 · Fund Raising/Other business matters: To consider Fund Raising and other business matters
- 30-May-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended March 31, 2026 and other business matters
- 13-Feb-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended December 31, 2025 and other business matters
Corporate actions
The corporate actions on record include 1 share split, 1 bonus issue. The ex-date is the first day the shares trade without the entitlement.
- Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share · ex-date 15-Oct-2024 · record date 15-Oct-2024
- Bonus 1:1 · ex-date 15-Oct-2024 · record date 15-Oct-2024
- Annual General Meeting · ex-date 19-Sep-2024 · book closure 20-Sep-2024 to 27-Sep-2024
- Annual General Meeting · ex-date 22-Sep-2023 · book closure 23-Sep-2023 to 29-Sep-2023
- Extra Ordinary General Meeting · ex-date 27-Dec-2022 · book closure 28-Dec-2022 to 04-Jan-2023
- Annual General Meeting · ex-date 23-Sep-2022 · book closure 24-Sep-2022 to 30-Sep-2022
- Annual General Meeting · ex-date 22-Sep-2021 · book closure 24-Sep-2021 to 30-Sep-2021
- Extra Ordinary General Meeting · ex-date 28-Jul-2021 · book closure 30-Jul-2021 to 05-Aug-2021
- Annual General Meeting · ex-date 22-Sep-2020 · book closure 24-Sep-2020 to 30-Sep-2020
Risk notice: low-priced and small-company shares can be illiquid, volatile and subject to manipulation, and shareholders can lose their entire investment. This page is a factual summary, not a recommendation to buy or sell Vaishali Pharma Limited.
Where to find Vaishali Pharma Limited's financials
Direct downloads from NSE:
- Annual report 2025-26 (PDF, 9.71 MB)
- Annual report 2024-25 (PDF, 8.43 MB)
- Annual report 2023-24 (PDF)
- Annual report 2022-23 (ZIP)
- Annual report 2021-22 (ZIP)
- Annual report 2020-21 (ZIP)
For full financial statements, shareholding detail and every company announcement, go to the source:
- NSE quote pageOfficial price, price band, surveillance status, shareholding pattern and corporate actions.
- Annual reports (NSE)Search “VAISHALI” to download Vaishali Pharma Limited's annual reports as filed with the exchange.
- Announcements and results (NSE)Search “VAISHALI” for quarterly results, board meetings and other company filings.
- ScreenerTen years of profit and loss, balance sheet, cash flow and key ratios.
- TradingView chartInteractive price chart with technical indicators.
- Google FinanceQuick price overview and recent news coverage.
- Yahoo FinanceHistorical prices you can download, plus summary statistics.
Other Pharmaceuticals stocks on MCX Trends
- Syncom Formulations (India) Limited (SYNCOMF · ₹21.19)
- Anlon Healthcare Limited (AHCL · ₹25.77)
- Sigachi Industries Limited (SIGACHI · ₹28.16)
- Vineet Laboratories Limited (VINEETLAB · ₹37.52)
- Ambalal Sarabhai Enterprises Limited (AMBALALSA · ₹38.62)
- Medico Remedies Limited (MEDICO · ₹18.31)
- Nectar Lifesciences Limited (NECLIFE · ₹10.31)
- Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM · ₹30.67)
Frequently asked questions
What is the Vaishali Pharma Limited share price?
Vaishali Pharma Limited (NSE: VAISHALI) closed at ₹7.02 in the end-of-day data for 16 November 2026. For a live price, use the NSE quote page or your broker, because this page is updated from end-of-day files.
Which sector does Vaishali Pharma Limited belong to?
NSE classifies Vaishali Pharma Limited under Pharmaceuticals, in the Healthcare sector.
What is the 52-week high and low of VAISHALI?
The 52-week high is ₹10.48 (31-OCT-2025) and the 52-week low is ₹4.75 (30-MAR-2026), according to NSE.
Is Vaishali Pharma Limited a penny stock?
At ₹7.02 the share trades below ₹10, so it appears on our list of penny stocks under ₹10. A low share price on its own says nothing about whether a company is cheap or expensive; market capitalisation, debt, profits and exchange surveillance status matter far more.
What is the promoter holding in Vaishali Pharma Limited?
Promoters and the promoter group held 31.61% of Vaishali Pharma Limited at the end of September 2026, according to the shareholding pattern filed with NSE.
What were Vaishali Pharma Limited's latest quarterly results?
For the quarter ended June 2026, Vaishali Pharma Limited reported total income of ₹23.47 crore and a net profit of ₹1.49 crore (EPS ₹0.11).
Where can I find Vaishali Pharma Limited's annual report and financial results?
Annual reports, quarterly results and other filings are published on the NSE corporate filings pages (search for VAISHALI). Screener also lays out several years of financial statements in one place. Links to all of these are above.